Back to VRTX
Vontobel Holding Ltd. VRTX Position History
Vertex Pharmaceuticals Incorporated • Healthcare
Quarters held
25
Latest value
$523K
Q3 2026
Peak value
$32.7M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $32.7M |
| Q4 2025 | $5K |
| Q4 2025 | $9.7M |
| Q4 2025 | $1.7M |
| Q4 2025 | $3.6M |
| Q4 2025 | $68K |
| Q1 2026 | $22.8M |
| Q1 2026 | $9.3M |
| Q1 2026 | $61K |
| Q1 2026 | $1.6M |
| Q1 2026 | $3.5M |
| Q1 2026 | $4K |
| Q2 2026 | $3.9M |
| Q2 2026 | $1.7M |
| Q2 2026 | $5K |
| Q2 2026 | $24.8M |
| Q2 2026 | $10M |
| Q2 2026 | $63K |
| Q2 2026 | $497K |
| Q3 2026 | $4M |
| Q3 2026 | $3.3M |
| Q3 2026 | $69K |
| Q3 2026 | $13.1M |
| Q3 2026 | $24M |
| Q3 2026 | $523K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $523K | 1.0K | — | — |
| Q3 2026 | $24M | 45.8K | — | — |
| Q3 2026 | $13.1M | 25.1K | — | — |
| Q3 2026 | $69K | 132 | — | — |
| Q3 2026 | $3.3M | 6.2K | — | — |
| Q3 2026 | $4M | 7.7K | — | — |
| Q2 2026 | $497K | 1.0K | — | — |
| Q2 2026 | $63K | 127 | — | — |
| Q2 2026 | $10M | 20.1K | — | — |
| Q2 2026 | $24.8M | 50.0K | — | — |
| Q2 2026 | $5K | 10 | — | — |
| Q2 2026 | $1.7M | 3.5K | — | — |
| Q2 2026 | $3.9M | 7.8K | — | — |
| Q1 2026 | $4K | 10 | — | — |
| Q1 2026 | $3.5M | 7.9K | — | — |
| Q1 2026 | $1.6M | 3.5K | — | — |
| Q1 2026 | $61K | 137 | — | — |
| Q1 2026 | $9.3M | 20.7K | — | — |
| Q1 2026 | $22.8M | 51.1K | — | — |
| Q4 2025 | $68K | 149 | — | — |
| Q4 2025 | $3.6M | 7.9K | — | — |
| Q4 2025 | $1.7M | 3.7K | — | — |
| Q4 2025 | $9.7M | 21.4K | — | — |
| Q4 2025 | $5K | 10 | — | — |
| Q4 2025 | $32.7M | 72.1K | — | — |
Other funds holding VRTX
$10.8B
$10.1B
$9.8B
$8.5B
$5.9B
$5.9B
$5.7B
$5.5B